Pouvons-nous vraiment traiter le cancer de la prostate avec des virus?

*This webinar is presented in French*

Presenter :
Dr. Jean-Simon Diallo
Date : Le mardi soir 11 avril

Thèmes abordés :

Nous discuterons du développement du cancer de la prostate et du développement de traitements innovateurs utilisant des virus dit "oncolytiques" pour le traitement de ce type de cancer. 
 

Dr. Jean-Simon Diallo :

Dr. Jean-Simon Diallo est un Scientifique à l'Institute de Recherche de l'Hôpital d'Ottawa et Professeur Associé au département de Biochimie, Microbiologie et Immunologie dans la Faculté de Médecine de l'Université d'Ottawa. Il a complété ses études doctorales à l'Université de Montréal étudiant le Cancer de la Prostate et son post-doctorat à l'Université d'Ottawa. Il travail depuis sur les thérapies combinées comprenant des virus oncolytiques pour le traitement du Cancer.





Expert AngleAbout Expert Angle

Expert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
 
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

   

Donate Now!






Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.
More

Researchers discover common markers of tumour hypoxia across 19 cancer types

Landmark pan-cancer study analyzes mutation signatures of low oxygen in more than 8,000 tumours
More

Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More


Click here for news archive